Table 2.
Ubi-c | Ig | Number of independent experiments | ||
---|---|---|---|---|
Malignant B cells | ||||
U266 | MM | 38.5 (11.52) | 311.1(144.48) | 4 |
MM.1S | MM | 43.6 (18.53) | 325.7 (26.98) | 3 |
RPMI 8226 | MM | 132.5 (30.35) | 28.8 (10.91) | 3 |
KMS-11 | MM | 96.6 (20.05) | 46.2 (22.61) | 3 |
Z-138 | MCL | 13.0 (5.91) | 14.9 (5.47) | 3 |
REC-1 | MCL | 7.0 (0.62) | 6.3 (0.71) | 5 |
IM-9 | B lymphoblastoid | 69.7 (7.25) | 23.1 (12.01) | 3 |
Malignant T cells | ||||
CCRF-CEM | 28.1 (18.88) | 12.1 (7.99) | 5 | |
MOLT-4 | 20.2 (7.55) | 14.6 (5.95) | 5 | |
Jurkat | 62.1 (4.69) | 43.2 (3.49) | 2 |
Data shown are the average (standard deviation) of the number of experiments indicated. MM: multiple myeloma; MCL: mantle cell lymphoma.